Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Kosan and NCI to clinically develop geldanamycin analogues

Nov. 20, 2002

ENMD-0995 trial for patients with multiple myeloma under way

Nov. 19, 2002

GC-C technology has potential as marker and target for gastric and esophageal cancers

Nov. 19, 2002

Helsinn grants CJ Corp. license and distribution rights for palonosetron in Korea

Nov. 19, 2002

New antiproliferative compounds isolated from fungal species

Nov. 19, 2002

Grant awarded for first clinical trial of squalamine in the treatment of prostate cancer

Nov. 18, 2002

Cell Therapeutics earns milestone payment

Nov. 18, 2002

ChromaVision and NewBiotics to collaborate on cancer therapeutic development

Nov. 18, 2002

Phase II trial of TNFerade initiated in patients with esophageal cancer

Nov. 18, 2002

Chemoprotective agent heads for clinical trials at ProMetic

Nov. 18, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...